Skip to main content

Closed

XBIO: Xenetic Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+19.0% / yr

Operating margin-75.1%

ROIC-34.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio7.93×

Xenetic Biosciences, Inc.

XBIONASDAQ Capital Market·USD·Closed

Xenetic Biosciences, Inc.

XBIONASDAQ·USD·Closed

$2.54

−0.59%

$2.54

−$0.01 (0.59%)

52W Range

5thpctl

Volume

0.52×avg

Mkt Cap

4.79MUSD

P/E

-2.1TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.52×avg

Market Cap

4.79MUSD

P/E Ratio

-2.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings